Literature DB >> 6175333

The British type of non-deletion HPFH: characterization of developmental changes in vivo and erythroid growth in vitro.

W G Wood, I A MacRae, P D Darbre, J B Clegg, D J Weatherall.   

Abstract

Further studies of a unique British family with a rare type of hereditary persistence of fetal haemoglobin (HPFH) have confirmed that this condition appears to result from a regulatory defect affecting globin gene expression. Adult heterozygotes for this disorder have 3.5-10.0% Hb F while homozygotes have 18-21% Hb F and in both cases the Hb F contained predominantly A gamma chains (89-94%). In all other respects these individuals were haematologically normal. Two obligate heterozygotes were studied from birth, at which time both the proportion of Hb F and the G gamma/A gamma ratio were completely normal. There was a delayed decline in Hb F which continued well into childhood and a parallel decline in the proportion of G gamma chains. The growth of erythroid bursts showed no difference in number, size or erythropoietin responsiveness between homozygous HPFH, heterozygous HPFH or normal family members. Haemoglobin synthesis in these bursts showed the normal pattern of asynchrony between gamma and beta chain synthesis but there was an overall increase in gamma chain production in the HPFH cases, particularly the homozygotes, compared to normal. In addition, the abnormal G gamma/A gamma ratio was faithfully reproduced in vitro. This condition appears to result, therefore, from a regulatory abnormality affecting the postnatal repression of gamma chain synthesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175333     DOI: 10.1111/j.1365-2141.1982.tb01935.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Increased Sp1 binding mediates erythroid-specific overexpression of a mutated (HPFH) gamma-globulin promoter.

Authors:  A Ronchi; S Nicolis; C Santoro; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

Review 2.  Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.

Authors:  Vigneshwaran Venkatesan; Saranya Srinivasan; Prathibha Babu; Saravanabhavan Thangavel
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

3.  Heterocellular hereditary persistence of fetal hemoglobin (HPFH). Molecular mechanisms of abnormal gamma-gene expression in association with beta thalassemia and linkage relationship with the beta-globin gene cluster.

Authors:  A Giampaolo; F Mavilio; N M Sposi; A Carè; A Massa; L Cianetti; M Petrini; R Russo; M D Cappellini; M Marinucci
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 4.  The thalassemias: molecular mechanisms of human genetic disease.

Authors:  R A Spritz; B G Forget
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

5.  Increased erythroid-specific expression of a mutated HPFH gamma-globin promoter requires the erythroid factor NFE-1.

Authors:  S Nicolis; A Ronchi; N Malgaretti; R Mantovani; B Giglioni; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

6.  The T----C substitution at -198 of the A gamma-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins.

Authors:  K D Fischer; J Nowock
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.